Chloroquine in the COVID-19 Pandemics and Quinine in the Cattle Plague Epidemics in the Eighteenth Century: Déjà Vu All Over Again
Main Article Content
Keywords
COVID-19, Cattle Plague, Chloroquine, Quinine, Ramazzini
Abstract
Drug treatment of diseases is not a usual task for occupational and environmental physicians. However, these professionals should be aware that some concerns on treatment during an epidemics were raised centuries ago.
This commentary discusses Bernardino Ramazzini's remarks made during a cattle plague epidemics occurring four centuries before the current COVID-19 emergency; he emphasised that prescription of some drugs usually given against every kind of fever deserved careful attention.
Ramazzini's contribution can be regarded as an early example of attention to evaluating the benefits and harmful effects of taking new drugs and witnesses the scientists' continuous effort to tackle new and unexpected health challenges.
Article Sidebar
Article Details
How to Cite
This work is licensed under a Creative Commons Attribution 4.0 International License.
OPEN ACCESS
All the articles of the European Journal of Oncology and Environmental Health are published with open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0 http://creativecommons.org/licenses/by/4.0/). This means that the author(s) retain copyright, but the content is free to download, distribute and adapt for commercial or non-commercial purposes, given appropriate attribution to the original article.
The articles in the previous edition of the Journal (European Journal of Oncology) are made available online with open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0 http://creativecommons.org/licenses/by/4.0/).
Upon submission, author(s) grant the Journal the license to publish their original unpublished work within one year, and the non exclusive right to display, store, copy and reuse the content. The CC-BY Creative Commons attribution license enables anyone to use the publication freely, given appropriate attribution to the author(s) and citing the Journal as the original publisher. The CC-BY Creative Commons attribution license does not apply to third-party materials that display a copyright notice to prohibit copying. Unless the third-party content is also subject to a CC-BY Creative Commons attribution license, or an equally permissive license, the author(s) must comply with any third-party copyright notices.
Giuliano Franco, Università Modena e Reggio Emilia
Dipartimento di Medicine e delle Specialità mediche
Universitò di Modena e Reggio Emilia